We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
Focus On
NEW In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax
Story image

Herceptin patents survive preliminary non-infringement challenge under new rules

Tuesday, October 23, 2018 @ 1:57 PM | By Andrew McIntosh

Significant amendments to the Patented Medicines (Notice of Compliance) Regulations came into force in September 2017. A purpose of these Regulations is to ensure that manufacturers of generic or biosimilar medicines...